Syncath Neuroscience

Multimodal monitoring and novel treatment of TBI patients - transforming the Neuro-ICU

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Raänana, Israel
  • Currency USD
  • Founded August 2018
  • Employees 5
  • Incorporation Type C-corp
  • Website syncath.com

Company Summary

Syncath Neuroscience develops a system to monitor and treat traumatic brain injury. Using a cardiac-synched disposable balloon catheter, we correctly measure the long-sought brain elastance parameter and substantially improve (so far in large animal models) brain perfusion, oxygenation and reduce ICP. Planned to commence FIH studies by end 2020. Strong IP, landmark publications in high-rank journals and conferences. Based in Israel; global S.A.B.

Team

  • Co-Founder, Prof of BME, former chairman of BME@TAU. BSc in EE@TAU; PhD in BME@Drexel. 30 years experience in the medical device industry. Founded several companies and led medical devices R&D.

Advisors

  • Dr Erez Nossek
    Unconfirmed
    Prof. Nino Stocchetti
    Unconfirmed

Previous Investors

  • Aharon Shapira
    Unconfirmed
    Ezriel Pines
    Unconfirmed
    Dr Gil N Mileikowsky
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free